SUBSCRIBE
SUBSCRIBE
News   Policy

US FDA Staff Weigh Urinary Effect of Valeant Pharmaceuticals International, GlaxoSmithKline Drug, Advisory Panel to Review Potiga on Wednesday

August 9, 2010 | 
1 min read
Reuters -- U.S. drug reviewers are concerned about urinary retention seen in some patients treated with an experimental epilepsy medicine from GlaxoSmithKline (GSK.L) and Valeant Pharmaceuticals (VRX.N), according to documents released on Monday.
Regulatory
GlaxoSmithKline Food and Drug Administration (FDA) Valeant Pharmaceuticals International
MORE ON THIS TOPIC
Pictured: CDC signage at its headquarters in Georg
Government
Hundreds of HHS Staffers Accuse RFK Jr. of ‘Sowing Public Mistrust’ Against CDC After Shooting at HQ
August 21, 2025
 · 
2 min read
 · 
Tristan Manalac
Trendy halftone collage. A hand holds a ringing alarm clock. Time, hurry up. Vector business concepts for graphic and web design, marketing and print materials, social media. Vector illustration
Regulatory
Two FDA Decisions for Regeneron’s Eylea HD Delayed Into Q4
August 21, 2025
 · 
2 min read
 · 
Tristan Manalac
Silver Spring, MD, USA - June 25, 2022: The FDA White Oak Campus, headquarters of the United States Food and Drug Administration, a federal agency of the Department of Health and Human Services (HHS).
Cancer
FDA Looks To Raise Survival Bar for Cancer Drug Approvals in New Draft Guidance
August 20, 2025
 · 
2 min read
 · 
Tristan Manalac
Healthcare, medical and doctor with kid patient and father holding baby for shot in hospital. Girl, children and family clinic nurse with vaccine for covid, virus or flu shot.
Vaccines
American Academy of Pediatrics Contradicts CDC, Recommends COVID-19 Shot for Kids
August 20, 2025
 · 
2 min read
 · 
Tristan Manalac